By contrast, other GLP-1 drugs such as exenatide and dulaglutide did not show similarly strong reductions in mental-illness risk in the summarized reporting
Rare but serious adverse effects are also emerging
Clinical evidence shows that weight loss benefits begin at lower doses, with some individuals experiencing substantial metabolic improvements at 0.5 mg to 1.0 mg weekly
Monitoring albumin, total protein, testosterone (in men), and Vitamin D levels during treatment helps identify early signs of muscle breakdown so you can adjust protein intake before significant loss occurs
Conclusion The researchers concluded that semaglutide was associated with a lower risk of incident diabetes than liraglutide among adults without recorded diabetes or cardiovascular disease who initiated formulations indicated for chronic weight management in routine clinical practice
It begins working shortly after the first injection by activating GLP-1 receptors that regulate appetite and blood sugar